Relationship between C - Reactive protein and stroke: A large prospective community based study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Liu, Yanfang ^a   Wang, Jing ^a   Zhang, Liqun ^b   Wang, Chunxue ^a   Wu, Jianwei ^a   Zhou, Yong ^a   Gao, Xiang ^c,d   Wang, Anxin ^a   Wu, Shouling ^e   Zhao, Xingquan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HEBEI UNITED UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; ADOLESCENT; BLOOD; CHINA; DEMOGRAPHY; INTRACRANIAL HEMORRHAGES; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RESIDENCE CHARACTERISTICS; STROKE; YOUNG ADULT;

EID: 84907004986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107017     Document Type: Article

References (37)

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disabilityadjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
2. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, et al. (2013) Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet 381: 1987-2015.
3. Paramsothy P, Knopp RH, Bertoni AG, Blumenthal RS, Wasserman BA, et al. (2010) Association of combinations of lipid parameters with carotid intimamedia thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56: 1034-1041.
4. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, et al. (2004) Inflammation as a possible link between coronary and carotid plaque instability. Circulation 109: 3158-3163.
5. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, et al. (2006) Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113: 38-43.
6. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, et al. (2005) C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112: 976-983.
7. Di Napoli M, Papa F, Bocola V (2001) C-Reactive Protein in Ischemic Stroke: An Independent Prognostic Factor. Stroke 32: 917-924.
8. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, et al. (2003) C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108: 166-170.
9. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, et al. (2003) Creactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107: 2016-2020.
10. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, et al. (2001) Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study. Stroke 32: 2575-2579.
11. Wilson PW, Nam BH, Pencina M, D'Agostino RB Sr, Benjamin EJ, et al. (2005) C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 165: 2473-2478.
12. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, et al. (2006) High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 114: 1591-1598.
13. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, et al. (2001) CReactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites. Circulation 104: 145-150.
14. Wu S, Li Y, Jin C, Yang P, Li D, et al. (2012) Intra-individual variability of highsensitivity C-reactive protein in Chinese general population. Int J Cardiol 157: 75-79.
15. WHO Task Force on Stroke and other Cerebrovascular Disorders (1989) Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 20: 1407-1431.
16. Pearson TA (2003) Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
17. Chei CL, Yamagishi K, Kitamura A, Kiyama M, Imano H, et al. (2011) Creactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis 217: 187-193.
18. Ballantyne CM, Hoogeveen RC, Bang H, Coresh J, Folsom AR, et al. (2005) Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 165: 2479-2484.
19. Gussekloo J, Schaap MCL, Frolich M, Blauw GJ, Westendorp RGJ (2000) CReactive Protein Is a Strong but Nonspecific Risk Factor of Fatal Stroke in Elderly Persons. Arterioscler Thromb Vasc Biol 20: 1047-1051.
20. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454.
21. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
22. Zhang YX, Cliff WJ, Schoefl GI, Higgins G (1999) Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 145: 375-379.
23. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, et al. (1993) C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82: 513-520.
24. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
25. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, et al. (2008) Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39: 2226-2230.
26. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, et al. (2006) Creactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke 37: 27-32.
27. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, et al. (2005) Creactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112: 900-905.
28. Caplan LR (1992) Intracerebral haemorrhage. Lancet 339: 656-658.
29. Gilbert JJ, Vinters HV (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 14: 915-923.
30. Miwa K, Tanaka M, Okazaki S, Furukado S, Sakaguchi M, et al. (2011) Relations of blood inflammatory marker levels with cerebral microbleeds. Stroke 42: 3202-3206.
31. Viswanathan A, Chabriat H (2006) Cerebral microhemorrhage. Stroke 37: 550-555.
32. Badjatia N, Carpenter A, Fernandez L, Schmidt JM, Mayer SA, et al. (2011) Relationship between C-reactive protein, systemic oxygen consumption, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 42: 2436-2442.
33. Teunissen LL, Rinkel GJ, Algra A, van Gijn J (1996) Risk factors for subarachnoid hemorrhage: a systematic review. Stroke 27: 544-549.
34. van Gijn J, Rinkel GJ (2001) Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124: 249-278.
35. Linn FH, Rinkel GJ, Algra A, van Gijn J (1996) Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a metaanalysis. Stroke 27: 625-629.
36. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al. (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373: 1175-1182.
37. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, et al. (2003) Proportion of different subtypes of stroke in China. Stroke 34: 2091-2096.